ATP Group

Apple Tree Partners (ATP) is a leading leader in life sciences venture creation, specializing in the founding and development of innovative biotechnology companies. Operating with a unique model, ATP provides both the initial capital and the operational leadership to translate breakthrough science into clinical-stage programs. The firm focuses on high-impact therapeutic areas including oncology, immunology, and metabolic diseases, utilizing a wide range of modalities from small molecules to advanced cell and gene therapies. ATP has successfully launched numerous prominent biotechs, such as Akero Therapeutics and Aiolos Bio, maintaining a deep involvement in their strategic and clinical progression. Their portfolio represents a broad pipeline of programs ranging from discovery to commercial-stage assets.